Multiple modes of hepatitis A virus transmission among methamphetamine users

American Journal of Epidemiology

Volumn 152, Issue 2, 2000, Pages 186-192

  Hutin, Yvan J F ^a   Sabin, Keith M ^a   Hutwagner, Lori C ^b   Schaben, Laura ^c   Shipp, Ginger M ^d   Lord, Destria M ^e   Conner, Julius S ^d   Quinlisk, M Patricia ^c   Shapiro, Craig N ^a   Bell, Beth P ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c IOWA DEPARTMENT OF PUBLIC HEALTH   (United States)

^d Polk Co Department of Public Health   (United States)

^e Wapello Co Dept of Public Health   (United States)

Author keywords

Case control studies; Disease outbreaks; Epidemiologic methods; Equipment contamination; Hepatitis A; Methamphetamine; Substance abuse, intravenous

Indexed keywords

IMMUNOGLOBULIN; METHAMPHETAMINE;

ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIC; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; NEEDLE; SUBSTANCE ABUSE; VACCINATION; VIRUS TRANSMISSION;

ADOLESCENT; AMPHETAMINE-RELATED DISORDERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HEPATITIS A; HUMANS; IOWA; MALE; METHAMPHETAMINE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 18544395999     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/152.2.186     Document Type: Article

References (34)

1. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 1996;45:1-30. (RR-15).
2. Lemon SM. The natural history of hepatitis A: the potential for transmission by transfusion of blood or blood products. Vox Sang 1994;67(suppl 4):19-23.
3. Summary of notifiable diseases, United States, 1997. MMWR Morb Mortal Wkly Rep 1998;46:3-87. (No. 54).
4. Hepatitis A among drug abusers. MMWR Morb Mortal Wkly Rep 1988;37:297-300, 305.
5. Harkess J, Gildon B, Istre GR. Outbreaks of hepatitis A among illicit drug users, Oklahoma, 1984-87. Am J Public Health 1989;79:463-6.
6. Schade C, Komorwska D. Continuing outbreak of hepatitis A linked with intravenous drug abuse in Multnomah County. Public Health Rep 1988;103:542-9.
7. Jin A, Bardsley J. Intravenous drug use and hepatitis A: an investigation of an outbreak. Can J Public Health 1990;81:79-81.
8. Widell A, Hansson BG, Moestrup T, et al. Acute hepatitis A, B and non-A, non-B in a Swedish community studied over a 10-year period. Scand J Infect Dis 1982;14:253-9.
9. Widell A, Hansson BG, Moestrup T, et al. Increased occurrence of hepatitis A with cyclic outbreaks among drug addicts in a Swedish community. Infection 1983;11:198-200.
10. Scheutz F, Skinhoj P, Mark I. Viral hepatitis among parenteral drug addicts attending a Danish addiction clinic. Scand J Infect Dis 1983;15:139-43.
11. Holter E, Siebke JC. Hepatitis A in young Norwegian drug addicts and prison inmates. Infection 1988;16:91-4.
12. Heath T, Lovegrove D, Westley-Wise V, et al. Communitywide hepatitis A outbreak in the Shoalhaven region, New South Wales. Commun Dis Intell 1997;21:1-4.
13. Hutin YJ, Bell BP, Marshall KL, et al. Identifying target groups for a potential vaccination program during a hepatitis A communitywide outbreak. Am J Public Health 1999;89: 918-21.
14. Sundkvist T, Johansson B, Widell A. Rectum carried drugs may spread hepatitis A among drug addicts. Scand J Infect Dis 1985;17:1-4.
15. Mast EE. Hepatitis A among intravenous drug users. Wisc Epidemiol Bull 1988;10:3-4. (No. 2).
16. Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1997;46:1-55. (RR-10).
17. Dean AG, Dean JA, Coulombier D, et al. Epi Info, version 6: a word-processing, database, and statistics program for public health on IBM-compatible microcomputers. Atlanta, GA: Centers for Disease Control and Prevention, 1974.
18. Zeger SL, Liang K-Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
19. Shaw FE Jr, Sudman JH, Smith SM, et al. A community-wide epidemic of hepatitis A in Ohio. Am J Epidemiol 1986;123: 1057-65.
20. Majeed FA, Stuart JM, Cartwright KA, et al. An outbreak of hepatitis A in Gloucester, UK. Epidemiol Infect 1992;109: 167-73.
21. Mannucci PM, Gdovin S, Gringeri A, et al. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. Ann Intern Med 1994;120:1-7.
22. Soucie JM, Robertson BH, Bell BP, et al. Hepatitis A virus infections associated with clotting factor concentrate in the United States. Transfusion 1998;38:573-9.
23. Koester SK, Hoffer L. "Indirect sharing": additional HIV risks associated with drug injection. AIDS Public Policy J 1994;9: 100-5.
24. Gossop M, Griffiths P, Powis B, et al. Continuing drug risk behaviour: shared use of injecting paraphernalia among London heroin injectors. AIDS Care 1997;9:651-60.
25. Shan SM, Shapshak P, Rivers JE, et al. Detection of HIV-1 DNA in needles/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:301-6.
26. Hagan H, McGough JP, Thiede H, et al. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol 1999;149:203-13.
27. Garfein RS, Vlahov D, Galai N, et al. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996;86:655-61.
28. Lettau LA, McCarthy JG, Smith MH, et al. Outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contacts. N Engl J Med 1987; 317:1256-62.
29. Recommendation of the Immunization Practices Advisory Committee (ACIP). Inactivated hepatitis B virus vaccine. MMWR Morb Mortal Wk;y Rep 1982;31:317-22, 327-8.
30. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999;48:1-37. (RR-12).
31. Farrell M, Battersby M, Strang J. Screening for hepatitis B and vaccination of injecting drug users in NHS drug treatment services. Br J Addict 1990;85:1657-9.
32. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1991;40:1-25. (RR-13).
33. Wacholder S, McLaughlin JK, Silverman DT, et al. Selection of controls in case-control studies. I. Principles. Am J Epidemiol 1992;135:1019-28.
34. Bell BP, Shapiro CN, Alter MJ, et al. The diverse patterns of hepatitis A epidemiology in the United States - implications for vaccination strategies. J Infect Dis 1998;178:1579-84.